On ECHEMI
Home > Drugs > Scleredema
Scleredema
Scleredema is a rare disease of unknown cause that usually has a benign course. It is also a systemic rheumatic disease: it is characterized by the sudden onset of severe symmetrical edema and induration of the skin throughout the body. The characteristics of the skin lesions are similar to the changes that occur during the edema phase of systemic scleroderma. The disease usually resolves on its own within 6 to 12 months, but occasionally it can last for decades. Curzio (1775) first reported the disease. Pifford (1876) discussed its clinical and pathological characteristics in more detail. Bushkle (1902) confirmed it as a special independent disease.
  • Site of disease:

    skin
  • Infectious :

    Not contagious
  • Frequent population:

    Newborns
  • Related symptoms:

    Insomnia Dysphagia Edema Papules Low Fever
Related Drugs
Hydrocortisone tablets
Indication: It is mainly used for replacement therapy of adrenal insufficiency and congenital adrenal hyperplasia.
Manufacturer:

Harbin Pharmaceutical Group Co., Ltd. GENERAL Pharm. FACTORY

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.